These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6289627)

  • 1. Affinity labeling and purification of the opiate receptor from rat brain.
    Bidlack JM; Abood LG; Munemitsu SM; Archer S; Gala D; Kreilick RW
    Adv Biochem Psychopharmacol; 1982; 33():301-9. PubMed ID: 6289627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of rat brain opioid (enkephalin) receptor by photoaffinity labeling.
    Yeung CW
    NIDA Res Monogr; 1986; 75():13-6. PubMed ID: 2828957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of the opiate receptor from rat brain.
    Bidlack JM; Abood LG; Osei-Gyimah P; Archer S
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):636-9. PubMed ID: 6264453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of bile acids as opioid receptor ligands in rat brain membranes.
    Bergasa NV; Dersch CM; Rothman RB
    Neurosci Lett; 2004 Mar; 358(1):68-70. PubMed ID: 15016436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.
    Liu-Chen LY; Chen C; Phillips CA
    Mol Pharmacol; 1993 Oct; 44(4):749-56. PubMed ID: 8232225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of solubilized opioid binding sites from rat brain by photoaffinity labeling and affinity chromatography using specific delta-opioid antagonist exorphin analogs.
    Loukas S; Panetsos F; Zioudrou C
    Prog Clin Biol Res; 1990; 328():97-100. PubMed ID: 2154828
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding properties of the pure opioid antagonist [3H](N-propyl)-noroxymorphone in rat brain membranes.
    Tóth G; Benyhe S; Hosztafi S; Borsodi A
    Neurobiology (Bp); 1993; 1(4):327-35. PubMed ID: 8069290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and purification of opioid receptor molecules of rat brain.
    Jin YC; Ye CY; Li Y; Suo CL; Li LY; Liu MQ; Jin XM; Mao ZM
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(1):1-7. PubMed ID: 2540493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone-sensitive, haloperidol-sensitive, [3H](+)SKF-10047-binding protein partially purified from rat liver and rat brain membranes: an opioid/sigma receptor?
    Tsao LI; Su TP
    Synapse; 1997 Feb; 25(2):117-24. PubMed ID: 9021892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate receptor heterogeneity: relative ligand affinities and molecular determinants of high affinity binding at different opiate receptors.
    Loew G; Toll L; Lawson J; Frenking G; Polgar W
    Prog Clin Biol Res; 1989; 289():411-32. PubMed ID: 2542973
    [No Abstract]   [Full Text] [Related]  

  • 14. [Solubilization and purification of opioid receptor molecules of rat brain].
    Jin YC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Apr; 11(2):79-86. PubMed ID: 2550157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opiate receptor(s) of the frog brain: soluble-phase separation of the macromolecular complexes of an agonist and an antagonist].
    Puget A; Meunier JC
    C R Seances Acad Sci III; 1983; 296(10):475-8. PubMed ID: 6307492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scatchard analysis of opiate receptor binding.
    Fischel SV; Medzihradsky F
    Mol Pharmacol; 1981 Sep; 20(2):269-79. PubMed ID: 6272086
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
    Graeser D; Neubig RR
    Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.